| Metric | Q3 2020 | Q2 2020 | Q3 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $352M | $360M | — | -2.2% | — |
| Op. Income | $63M | $50M | — | 26.7% | — |
| Gross Margin | 77.5% | 76.9% | — | 0.6pp | — |
| Net Margin | 9.9% | 2.0% | — | 7.9pp | — |
| EPS (Diluted) | $0.30 | $0.06 | — | 400.0% | — |
| Free Cash Flow | $88M | $82M | — | 7.3% | — |
| Item | Amount |
|---|---|
| REVENUE | $352M |
| Cost of Revenue | $79M |
| GROSS PROFIT | $272M |
| R&D Expenses | $61M |
| Selling & Marketing | $105M |
| General & Administrative | $36M |
| SG&A Expenses | $140M |
| Other Expenses | $7M |
| Operating Expenses | $209M |
| Cost & Expenses | $288M |
| OPERATING INCOME | $63M |
| Interest Income | $700.0K |
| Interest Expense | $20M |
| Other Income/Expenses | -$19M |
| INCOME BEFORE TAX | $45M |
| Income Tax Expense | $10M |
| Net Income from Continuing Ops | $35M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $35M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $35M |
| D&A | $31M |
| EBIT | $64M |
| EBITDA | $95M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $352M |
| Cost of Revenue | $79M |
| GROSS PROFIT | $272M |
| R&D Expenses | $61M |
| Selling & Marketing | $105M |
| General & Administrative | $36M |
| SG&A Expenses | $140M |
| Other Expenses | $7M |
| Operating Expenses | $209M |
| Cost & Expenses | $288M |
| OPERATING INCOME | $63M |
| Interest Income | $700.0K |
| Interest Expense | $20M |
| Other Income/Expenses | -$19M |
| INCOME BEFORE TAX | $45M |
| Income Tax Expense | $10M |
| Net Income from Continuing Ops | $35M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $35M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $35M |
| D&A | $31M |
| EBIT | $64M |
| EBITDA | $95M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $35M |
| Depreciation & Amortization | $31M |
| Stock-Based Compensation | $25M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$1M |
| Change in Working Capital | $15M |
| OPERATING CASH FLOW | $105M |
| Capital Expenditure | -$16M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$16M |
| Sales/Maturities of Investments | $16M |
| Other Investing Activities | -$15M |
| NET CASH FROM INVESTING | -$20M |
| Net Debt Issuance | -$510M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$25M |
| NET CASH FROM FINANCING | -$536M |
| FREE CASH FLOW | $88M |
| Net Change in Cash | -$450M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $377M |
| Short-Term Investments | $26M |
| Net Receivables | $319M |
| Inventory | $0 |
| Other Current Assets | $52M |
| TOTAL CURRENT ASSETS | $847M |
| PP&E (Net) | $253M |
| Goodwill | $1.6B |
| Intangible Assets | $247M |
| Long-Term Investments | $32M |
| Tax Assets | $197M |
| Other Non-Current Assets | $195M |
| TOTAL NON-CURRENT ASSETS | $2.5B |
| TOTAL ASSETS | $3.4B |
| Account Payables | $30M |
| Short-Term Debt | $0 |
| Deferred Revenue | $396M |
| Other Current Liabilities | $90M |
| TOTAL CURRENT LIABILITIES | $666M |
| Long-Term Debt | $1.1B |
| Deferred Revenue NC | $9M |
| Deferred Tax Liabilities | $17M |
| Other Non-Current Liabilities | $52M |
| TOTAL NON-CURRENT LIABILITIES | $1.4B |
| TOTAL LIABILITIES | $2.0B |
| Common Stock | $1M |
| Additional Paid-In Capital | $1.6B |
| Retained Earnings | -$116M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$110M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.3B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.3B |
| TOTAL LIABILITIES & EQUITY | $3.4B |
| Total Debt | $1.3B |
| Net Debt | $963M |
